Jan P. Deroose

Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas

Jan P. Deroose, Alexander M.M. Eggermont, Albertus N. van Geel et al. · Journal of Clinical Oncology · 2011 · 100 citations · Full text

Medicine, Oncology, Surgery +10

20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters

Jan P. Deroose, Alexander M.M. Eggermont, Albertus N. van Geel et al. · Annals of Surgical Oncology · 2011 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Hepatic steatosis is not always a contraindication for cadaveric liver transplantation

Jan P. Deroose, Geert Kazemier, Pieter E. Zondervan et al. · HPB · 2011 · 68 citations · Full text

Medicine, Surgery, Hepatology +7

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases

Jan P. Deroose, Dirk J. Grünhagen, A.N. van Geel et al. · British journal of surgery · 2011 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis

Danique L. M. van Broekhoven, Jan P. Deroose, Sylvie Bonvalot et al. · British journal of surgery · 2014 · 38 citations · Full text

Medicine, Oncology, Pharmacology +13